Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Brief Commentary
Cardio Oncology with ACOS
Case Report
Case Series
Conference Review
Consensus Statement
Current Issue
Editorial
Erratum
Letter to Editor
Media and News
Molecular Insight Story
New Drug Update
News
Original Article
Position Paper
Response to the letter
Review Article
Short Communication

Most Viewed Articles


Articles Fulltext downloads PDF downloads Total downloads
Short Communication
Driver mutations in oncogenesis
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_26_2020
26,767 2,899 29,666
Review Article
Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2023
21,983 1,856 23,839
Original Article
Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_15_2023
20,851 1,718 22,569
Editorial
Challenging conventional wisdom in molecular oncology: New perspectives
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2023
20,879 1,656 22,535
Review Article
Molecular oncology and the role of artificial intelligence in advancing cancer treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_17_2023
20,665 1,205 21,870
Short Communication
Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_30_2020
17,939 2,438 20,377
Case Report
Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_16_2023
17,279 1,290 18,569
News
Editorial board tribute to Dr. Amit Verma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
14,707 1,804 16,511
Review Article
Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_8_2022
12,239 4,111 16,350
Case Report
Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_5_2022
11,278 4,766 16,044
Case Report
Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2023
13,797 1,630 15,427
Case Report
Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_16_2021
13,476 1,612 15,088
Review Article
Potential therapeutic molecular targets for better outcomes for patients with lung cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_27_2022
14,294 614 14,908
New Drug Update
Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2021
13,289 1,606 14,895
Review Article
Combination of PARPi and anti-PD-L1 therapies in ovarian cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2022
14,028 800 14,828
Cardio Oncology with ACOS
Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_1_2022
11,195 3,608 14,803
Review Article
Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_29_2022
13,311 1,417 14,728
Original Article
Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_2_2022
10,735 3,643 14,378
Review Article
Immune dynamics of SARS-CoV-2 virus evolution
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_26_2021
9,964 3,860 13,824
Case Series
Dual driver in non-small cell lung carcinoma – therapeutic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2021
11,653 1,933 13,586
Review Article
Advances in immunotherapy for metastatic esophageal cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_14_2022
9,726 3,598 13,324
Review Article
Is continuous infusion of high-dose ifosfamide, a safe option? Drug review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_21_2019
10,517 2,747 13,264
Case Report
L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2023, Volume: 8, Issue: 3, September-December
DOI: 10.25259/IJMIO_11_2023
12,172 940 13,112
Review Article
Immuno-oncological era of breast cancer: A progressive path to better treatment
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_3_2022
8,463 4,580 13,043
Review Article
The evolving role of precision medicine in the management of advanced sarcomas – A mini review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_6_2021
11,083 1,893 12,976
Case Report
Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_11_2022
10,555 2,277 12,832
Editorial
Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2019
6,293 6,492 12,785
Review Article
Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_12_2021
10,560 2,080 12,640
Review Article
Immuno-oncology of differentiated thyroid cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_36_2020
9,918 2,555 12,473
Conference Review
6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_20_2021
10,851 1,489 12,340
Brief Commentary
ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_10_2021
10,171 2,071 12,242
Erratum
Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, October
DOI: 10.25259/IJMIO_05_2020_ER
11,140 1,064 12,204
Case Report
Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_2_2019
7,689 4,435 12,124
Review Article
A compendium of population wide DNA methylation profile for oral cancer in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_2_2021
9,178 2,932 12,110
Case Report
Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2021
10,408 1,628 12,036
Brief Commentary
Breast cancer prognostic tools: A promising Indian option
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_15_2020
8,111 3,627 11,738
Letter to Editor
Letter to editor
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_10_2022
7,854 3,545 11,399
Brief Commentary
Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 3, September-December
DOI: 10.25259/IJMIO_7_2021
9,341 2,038 11,379
Case Report
Metastatic endometrial carcinoma responsive to pembrolizumab
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2020
6,530 4,785 11,315
Review Article
Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 2, May – August
DOI: 10.25259/IJMIO_12_2022
7,225 4,068 11,293
Review Article
Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_18_2019
6,215 4,987 11,202
Review Article
Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_17_2019
5,678 5,324 11,002
Review Article
The Cancer Genomic Atlas – “TO CONQUER CANCER”
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2021, Volume: 6, Issue: 2, May-August
DOI: 10.25259/IJMIO_28_2020
8,633 2,349 10,982
Original Article
Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
DOI: 10.25259/IJMIO_1_2019
5,210 5,688 10,898
Review Article
Molecular genetics changes in gallbladder carcinoma
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 2, May-August
DOI: 10.25259/IJMIO_19_2019
7,461 3,267 10,728
Case Report
A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 3, September-December
DOI: 10.25259/IJMIO_13_2022
8,574 1,958 10,532
Review Article
Understanding immunotherapy and CAR-T-cells: A narrative review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2024, Volume: 9, Issue: 1, January-April
DOI: 10.25259/IJMIO_22_2023
9,389 780 10,169
Editorial
Molecular insights into tumor microenvironment and targeted therapies
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2022, Volume: 7, Issue: 1, January-April
DOI: 10.25259/IJMIO_28_2021
7,770 2,383 10,153
Position Paper
Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
DOI: 10.25259/IJMIO-6-2019
5,629 4,490 10,119
Editorial
Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
DOI: 10.25259/IJMIO_23_2019
5,282 4,806 10,088